Previous month:
July 2014
Next month:
October 2014

Ruxolitinib Successfully Reverses Alopecia Offerring Potential Cure for Autoimmune Hair Loss

Another JAK inhibitor, Ruxolitinib, suppresses immune system activity similar to Tofacitinib(Xeljanz). Ruxolitinib was successfully tested in NY by Dr. Angelina Christiano, reversing severe autoimmune alopecia areata in the majority of the small number of patients tested. --DrBauman